119 related articles for article (PubMed ID: 10383382)
1. Competitive, reversible inhibition of cytosolic phospholipase A2 at the lipid-water interface by choline derivatives that partially partition into the phospholipid bilayer.
Burke JR; Witmer MR; Zusi FC; Gregor KR; Davern LB; Padmanabha R; Swann RT; Smith D; Tredup JA; Micanovic R; Manly SP; Villafranca JJ; Tramposch KM
J Biol Chem; 1999 Jul; 274(27):18864-71. PubMed ID: 10383382
[TBL] [Abstract][Full Text] [Related]
2. A beta-lactam inhibitor of cytosolic phospholipase A2 which acts in a competitive, reversible manner at the lipid/water interface.
Burke JR; Gregor KR; Padmanabha R; Banville J; Witmer MR; Davern LB; Manly SP; Tramposch KM
J Enzyme Inhib; 1998 Jun; 13(3):195-206. PubMed ID: 9629537
[TBL] [Abstract][Full Text] [Related]
3. BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation models.
Burke JR; Davern LB; Stanley PL; Gregor KR; Banville J; Remillard R; Russell JW; Brassil PJ; Witmer MR; Johnson G; Tredup JA; Tramposch KM
J Pharmacol Exp Ther; 2001 Jul; 298(1):376-85. PubMed ID: 11408565
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of inhibition of human nonpancreatic secreted phospholipase A2 by the anti-inflammatory agent BMS-181162.
Burke JR; Gregor KR; Tramposch KM
J Biol Chem; 1995 Jan; 270(1):274-80. PubMed ID: 7814386
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation and calcium influx are not sufficient for the activation of cytosolic phospholipase A2 in U937 cells: requirement for a Gi alpha-type G-protein.
Burke JR; Davern LB; Gregor KR; Todderud G; Alford JG; Tramposch KM
Biochim Biophys Acta; 1997 Sep; 1341(2):223-37. PubMed ID: 9357962
[TBL] [Abstract][Full Text] [Related]
6. Presence of glycerol masks the effects of phosphorylation on the catalytic efficiency of cytosolic phospholipase A2.
Burke JR; Guenther MG; Witmer MR; Tredup JA; Hail ME; Micanovic R; Villafranca JJ
Arch Biochem Biophys; 1997 May; 341(1):177-85. PubMed ID: 9143367
[TBL] [Abstract][Full Text] [Related]
7. The size and curvature of anionic covesicle substrate affects the catalytic action of cytosolic phospholipase A2.
Burke JR; Witmer MR; Tredup JA
Arch Biochem Biophys; 1999 May; 365(2):239-47. PubMed ID: 10328818
[TBL] [Abstract][Full Text] [Related]
8. Interfacial catalysis by human 85 kDa cytosolic phospholipase A2 on anionic vesicles in the scooting mode.
Bayburt T; Gelb MH
Biochemistry; 1997 Mar; 36(11):3216-31. PubMed ID: 9115999
[TBL] [Abstract][Full Text] [Related]
9. Continuous, vesicle-based fluorimetric assays of 14- and 85-kDa phospholipases A2.
Bayburt T; Yu BZ; Street I; Ghomashchi F; Laliberté F; Perrier H; Wang Z; Homan R; Jain MK; Gelb MH
Anal Biochem; 1995 Nov; 232(1):7-23. PubMed ID: 8600835
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cytosolic phospholipase A2 by annexin V in differentiated permeabilized HL-60 cells. Evidence of crucial importance of domain I type II Ca2+-binding site in the mechanism of inhibition.
Mira JP; Dubois T; Oudinet JP; Lukowski S; Russo-Marie F; Geny B
J Biol Chem; 1997 Apr; 272(16):10474-82. PubMed ID: 9099690
[TBL] [Abstract][Full Text] [Related]
11. Cooperativity and binding in the mechanism of cytosolic phospholipase A2.
Burke JR; Witmer MR; Tredup J; Micanovic R; Gregor KR; Lahiri J; Tramposch KM; Villafranca JJ
Biochemistry; 1995 Nov; 34(46):15165-74. PubMed ID: 7578131
[TBL] [Abstract][Full Text] [Related]
12. Cytosolic phospholipase A2 shows burst kinetics consistent with the slow, reversible formation of a dead-end complex.
Guenther MG; Witmer MR; Burke JR
Arch Biochem Biophys; 2002 Feb; 398(1):101-8. PubMed ID: 11811954
[TBL] [Abstract][Full Text] [Related]
13. Membrane penetration of cytosolic phospholipase A2 is necessary for its interfacial catalysis and arachidonate specificity.
Lichtenbergova L; Yoon ET; Cho W
Biochemistry; 1998 Oct; 37(40):14128-36. PubMed ID: 9760249
[TBL] [Abstract][Full Text] [Related]
14. The interaction of phospholipase A2 with phospholipid analogues and inhibitors.
Yu L; Deems RA; Hajdu J; Dennis EA
J Biol Chem; 1990 Feb; 265(5):2657-64. PubMed ID: 2303420
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of monocyte chemotaxis to C-C chemokines by antisense oligonucleotide for cytosolic phospholipase A2.
Locati M; Lamorte G; Luini W; Introna M; Bernasconi S; Mantovani A; Sozzani S
J Biol Chem; 1996 Mar; 271(11):6010-6. PubMed ID: 8626384
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of U937 cells enables a phospholipase D-dependent pathway of cytosolic phospholipase A2 activation.
Burke JR; Davern LB; Gregor KR; Owczarczak LM
Biochem Biophys Res Commun; 1999 Jun; 260(1):232-9. PubMed ID: 10381372
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of cytosolic phospholipase A2 as mediator of the enhanced arachidonic acid release from dimethyl sulphoxide differentiated U937 cells.
Withnall MT; Pennington A; Wiseman D
Biochem Pharmacol; 1995 Nov; 50(11):1893-902. PubMed ID: 8615870
[TBL] [Abstract][Full Text] [Related]
18. Properties and purification of an arachidonoyl-hydrolyzing phospholipase A2 from a macrophage cell line, RAW 264.7.
Leslie CC; Voelker DR; Channon JY; Wall MM; Zelarney PT
Biochim Biophys Acta; 1988 Dec; 963(3):476-92. PubMed ID: 3143418
[TBL] [Abstract][Full Text] [Related]
19. Phospholipase D is involved in cytosolic phospholipase A2-dependent selective release of arachidonic acid by fMLP-stimulated rat neutrophils.
Fujita K; Murakami M; Yamashita F; Amemiya K; Kudo I
FEBS Lett; 1996 Oct; 395(2-3):293-8. PubMed ID: 8898114
[TBL] [Abstract][Full Text] [Related]
20. Leukotriene B4 stimulates the release of arachidonate in human neutrophils via the action of cytosolic phospholipase A2.
Burke JR; Davern LB; Gregor KR; Tramposch KM
Biochim Biophys Acta; 1997 Oct; 1359(1):80-8. PubMed ID: 9398088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
